dasatinib
- Product NDC
- 70710-1743
- 11-digit product format
- 707101743
- Labeler code
- 70710
- Product ID
- 70710-1743_46121457-8af5-4016-827f-ead2f0b33b83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasatinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA218719
- Marketing category
- ANDA
- Marketing start
- 2025-03-03
- Substance
- DASATINIB
- Active strength
- 70 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- dasatinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 70 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70710-1743-6 | dasatinib | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70710-1743 | DASATINIB TABLET [ZYDUS PHARMACEUTICALS USA INC.] | 1 | Current NDC, 1 package rows | 20250309_11703145-29ea-480a-9810-bc70663b783f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70710-1743-6 | 70710174306 | 60 TABLET in 1 BOTTLE (70710-1743-6) | 60 tablet | 2025-03-03 | No | No | Current |